Literature DB >> 23333022

Cost of prostate image-guided radiation therapy: results of a randomized trial.

Lionel Perrier1, Magali Morelle, Pascal Pommier, Jean-Léon Lagrange, Agnès Laplanche, Philippe Dudouet, Stéphane Supiot, Bruno Chauvet, Tan-Dat Nguyen, Gilles Crehange, Véronique Beckendorf, Françoise Pene, Xavier Muracciole, Jean-Marc Bachaud, Elisabeth Le Prisé, Renaud de Crevoisier.   

Abstract

PURPOSE: This cost analysis aimed to quantify the cost of IGRT in relation to IGRT frequency and modality with Cone Beam Computed Tomography (CBCT) or orthogonal electronic portal imaging with fiducial markers (EPI-FM).
MATERIAL AND METHODS: Patients undergoing IGRT for localized prostate cancer were randomized into two prostate control frequencies (daily or weekly). Costs were calculated based on the micro-costing results according to hospitals' perspectives (in Euros, 2009) and the time horizon was radiation therapy.
RESULTS: A total of 208 patients were enrolled in seven French cancer centers. A total of 6865 fractions were individually analyzed. The mean total treatment fraction duration was 21.0 min for daily CBCT and 18.3 min for daily EPI-FM. Increasing the control frequency from weekly to daily increased the mean treatment fraction duration by 7.3 min (+53%) for CBCT and 1.7 min (+10%) for EPI-FM (p ≤ 0.01). The mean additional cost per patient of daily controls compared with weekly controls was €679 and €187 for CBCT and EPI-FM, respectively (p<0.0001).
CONCLUSIONS: The incremental costs due to different prostate IGRT strategies are relatively moderate, suggesting that daily IGRT combined with intensity-modulated RT (IMRT) could be administered in cases of high-dose radiation delivery to the prostate.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23333022     DOI: 10.1016/j.radonc.2012.11.011

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  13 in total

1.  Acute Toxicity in Hypofractionated/Stereotactic Prostate Radiotherapy of Elderly Patients: Use of the Image-guided Radio Therapy (IGRT) Clarity System.

Authors:  Rossella DI Franco; Valentina Borzillo; Domingo Alberti; Gianluca Ametrano; Angela Petito; Andrea Coppolaro; Ilaria Tarantino; Sabrina Rossetti; Sandro Pignata; Gelsomina Iovane; Sisto Perdonà; Giuseppe Quarto; Giovanni Grimaldi; Alessandro Izzo; Luigi Castaldo; Raffaele Muscariello; Marcello Serra; Gaetano Facchini; Paolo Muto
Journal:  In Vivo       Date:  2021 May-Jun       Impact factor: 2.155

2.  Toxicity reduction required for MRI-guided radiotherapy to be cost-effective in the treatment of localized prostate cancer.

Authors:  Leif-Erik D Schumacher; Alan Dal Pra; Sarah E Hoffe; Eric A Mellon
Journal:  Br J Radiol       Date:  2020-08-12       Impact factor: 3.039

Review 3.  The future of MRI in radiation therapy: Challenges and opportunities for the MR community.

Authors:  Rosie J Goodburn; Marielle E P Philippens; Thierry L Lefebvre; Aly Khalifa; Tom Bruijnen; Joshua N Freedman; David E J Waddington; Eyesha Younus; Eric Aliotta; Gabriele Meliadò; Teo Stanescu; Wajiha Bano; Ali Fatemi-Ardekani; Andreas Wetscherek; Uwe Oelfke; Nico van den Berg; Ralph P Mason; Petra J van Houdt; James M Balter; Oliver J Gurney-Champion
Journal:  Magn Reson Med       Date:  2022-09-21       Impact factor: 3.737

4.  Volumetric-Modulated Arc Radiotherapy with Daily Image-Guidance Carries Better Toxicity Profile for Higher Risk Prostate Cancer.

Authors:  Ahmad I Ghanem; Amr A Elsaid; Mohamed A Elshaikh; Gehan A Khedr
Journal:  Asian Pac J Cancer Prev       Date:  2021-01-01

5.  Significance of image guidance to clinical outcomes for localized prostate cancer.

Authors:  Qiuzi Zhong; Hong Gao; Gaofeng Li; Xia Xiu; Qinhong Wu; Ming Li; Yonggang Xu
Journal:  Biomed Res Int       Date:  2014-07-13       Impact factor: 3.411

6.  Health technology assessment of image-guided radiotherapy (IGRT): A systematic review of current evidence.

Authors:  Jalal Arabloo; Pejman Hamouzadeh; Seyedeh Maryam Mousavinezhad; Mohammadreza Mobinizadeh; Alireza Olyaeemanesh; Morvarid Pooyandjoo
Journal:  Med J Islam Repub Iran       Date:  2016-01-18

7.  Comparison of setup accuracy of three different image assessment methods for tangential breast radiotherapy.

Authors:  Vikneswary Batumalai; Penny Phan; Callie Choong; Lois Holloway; Geoff P Delaney
Journal:  J Med Radiat Sci       Date:  2016-05-31

8.  Nomogram to predict rectal toxicity following prostate cancer radiotherapy.

Authors:  Jean-Bernard Delobel; Khemara Gnep; Juan David Ospina; Véronique Beckendorf; Ciprian Chira; Jian Zhu; Alberto Bossi; Taha Messai; Oscar Acosta; Joël Castelli; Renaud de Crevoisier
Journal:  PLoS One       Date:  2017-06-22       Impact factor: 3.240

9.  Three-dimensional surface and ultrasound imaging for daily IGRT of prostate cancer.

Authors:  Marco Krengli; Gianfranco Loi; Carla Pisani; Debora Beldì; Giuseppina Apicella; Valentina Amisano; Marco Brambilla
Journal:  Radiat Oncol       Date:  2016-12-13       Impact factor: 3.481

10.  The impact of the three degrees-of-freedom fiducial marker-based setup compared to soft tissue-based setup in hypofractionated intensity-modulated radiotherapy for prostate cancer.

Authors:  Satoshi Tanabe; Satoru Utsunomiya; Eisuke Abe; Hiraku Sato; Atsushi Ohta; Hironori Sakai; Takumi Yamada; Motoki Kaidu; Hidefumi Aoyama
Journal:  J Appl Clin Med Phys       Date:  2019-05-04       Impact factor: 2.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.